Cite
HARVARD Citation
Roy, I. et al. (2022). Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T‐cell therapy for B‐cell non‐Hodgkin lymphoma. British journal of haematology. pp. 71-75. [Online].